Sophie Robinson
Senior Associate at Cure Ventures
About
A neuroscientist with over a decade of academic and industry research experience in the US and abroad. Conducted doctoral research on neurodegeneration and FTD mechanisms at German research institutes, and worked in clinical operations at Genentech. Transitioning from academic research to biotech venture capital.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures